Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis

OBJECTIVE: To systematically evaluate the effects of pioglitazone in the treatment of patients with prediabetes or T2DM combined with NAFLD. METHODS: The Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and ClinicalTrials databases were searched until August 2020 for publications wr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Jingxuan, Fu, Jianfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115121/
https://www.ncbi.nlm.nih.gov/pubmed/33995271
http://dx.doi.org/10.3389/fendo.2021.615409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115121/
https://www.ncbi.nlm.nih.gov/pubmed/33995271
http://dx.doi.org/10.3389/fendo.2021.615409

Ejemplares similares